Phase IIa trial of NM-108 in patients with diabetic macular oedema
Latest Information Update: 15 Jun 2015
At a glance
- Drugs NM 108 (Primary)
- Indications Diabetic macular oedema
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 15 Jun 2015 New trial record